Treating the diabetic patient with coronary disease.

[2] Fishman DL, Leon MB, Bairn DA et al. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501. [3] Colombo A, Hall P, Nakamura S el al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88. [4] Monce MC, Zemour G, Benveniste E et al Intracoronary stenting without coumadin: one month results of a French multicenter study Cathet Cardiovasc Diagn 1995, 351-7. [5] Morice MC, Valeix B, Marco J et al. Preliminary results of the MUST trial. Major clinical events during the first month J Am Coll Cardiol 1996 (Feb); 137A. [6] de Jaegere P, Mudra H, Almagor Y et al In-hospital and 1-month clinical results of an international study testing the concept of IVUS guided optimised stent expansion alleviating the need of systemic anticoagulation. J Am Coll Cardiol 1996 (Feb); 137A [7] Lablanche J-M, McFadden EP, Bonnet J-L et al. Combmed antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J 1996; 17: 1373-80. [8] Goods CM, Al-Shaibi KF, Yadav SS et al. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation 1996; 93. 1803—8 [9J Schomig A, Neumann F-J, Kastrati A et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9 [10] Serruys PW, Emanuelsson H, van der Giessen el al. Heparincoated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study Circulation 1996, 93: 412-22.